Trial Profile
A phase II study of cenderitide for the treatment of acute decompensated heart failure (ADHF)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2014
Price :
$35
*
At a glance
- Drugs Cenderitide (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- 22 Nov 2014 New trial record